APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aurora Kinase A

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Aurora Kinase A Market Outlook and Growth Opportunities 2026

19 December 2025193 pages

Choose your research edition.

Industry ResearchAurora Kinase A Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Aurora Kinase A Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Aurora Kinase A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aurora Kinase A Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Aurora Kinase A Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Aurora Kinase A market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Aurora Kinase A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Aurora Kinase A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aurora Kinase A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Aurora Kinase A market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Aurora Kinase A market include Sanofi, Merck & Co., Inc., Amgen Inc., AbbVie Inc., Vichem Chemie Research Ltd., Vertex Pharmaceuticals Incorporated, Taiho Pharmaceutical Co., Ltd., Sigma-Tau S.p.A. and Sareum Holdings Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Aurora Kinase A market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Aurora Kinase A and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Aurora Kinase A sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Aurora Kinase A market size, projected growth trends, production technologies, key applications, and end-use industries.

Aurora Kinase A Segment by Company

Sanofi

Merck & Co., Inc.

Amgen Inc.

AbbVie Inc.

Vichem Chemie Research Ltd.

Vertex Pharmaceuticals Incorporated

Taiho Pharmaceutical Co., Ltd.

Sigma-Tau S.p.A.

Sareum Holdings Plc

Millennium Pharmaceuticals, Inc.

CASI Pharmaceuticals Inc.

Astex Pharmaceuticals, Inc.

Aurora Kinase A Segment by Type

AMG-900

Ilorasertib

ENMD-2076

Danusertib

Others

Aurora Kinase A Segment by Application

Brain Tumor

Ovarian Cancer

Anaplastic Large Cell Lymphoma

Others

Aurora Kinase A Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Aurora Kinase A status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Aurora Kinase A market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Aurora Kinase A significant trends, drivers, influence factors in global and regions.

6. To analyze Aurora Kinase A competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase A and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase A.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Aurora Kinase A market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Aurora Kinase A industry.

Chapter 3: Detailed analysis of Aurora Kinase A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Aurora Kinase A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Aurora Kinase A in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Aurora Kinase A Industry Trends Table 2. Aurora Kinase A Industry Drivers Table 3. Aurora Kinase A Industry Opportunities and Challenges Table 4. Aurora Kinase A Industry Restraints Table 5. Global Aurora Kinase A Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Aurora Kinase A Revenue Share by Company (2021-2026) Table 7. Global Aurora Kinase A Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Aurora Kinase A Sales Volume Share by Company (2021-2026) Table 9. Global Aurora Kinase A Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Aurora Kinase A Company Ranking, (2024-2026) & (USD Million) Table 11. Global Aurora Kinase A Key Company Manufacturing Base & Headquarters Table 12. Global Aurora Kinase A Company, Product Type & Application Table 13. Global Aurora Kinase A Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Aurora Kinase A by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of AMG-900 Table 18. Significant Companies of Ilorasertib Table 19. Significant Companies of ENMD-2076 Table 20. Significant Companies of Danusertib Table 21. Significant Companies of Others Table 22. Global Aurora Kinase A Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Aurora Kinase A Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Aurora Kinase A Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Aurora Kinase A Sales Volume Share by Type (2021-2026) Table 26. Global Aurora Kinase A Sales Volume Share by Type (2027-2032) Table 27. Global Aurora Kinase A Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Aurora Kinase A Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Aurora Kinase A Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Aurora Kinase A Sales Value Share by Type (2021-2026) Table 31. Global Aurora Kinase A Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Brain Tumor Table 33. Significant Companies of Ovarian Cancer Table 34. Significant Companies of Anaplastic Large Cell Lymphoma Table 35. Significant Companies of Others Table 36. Global Aurora Kinase A Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Aurora Kinase A Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Aurora Kinase A Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Aurora Kinase A Sales Volume Share by Application (2021-2026) Table 40. Global Aurora Kinase A Sales Volume Share by Application (2027-2032) Table 41. Global Aurora Kinase A Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Aurora Kinase A Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Aurora Kinase A Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Aurora Kinase A Sales Value Share by Application (2021-2026) Table 45. Global Aurora Kinase A Sales Value Share by Application (2027-2032) Table 46. Global Aurora Kinase A Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Aurora Kinase A Sales by Region (2021-2026) & (K Units) Table 48. Global Aurora Kinase A Sales Market Share by Region (2021-2026) Table 49. Global Aurora Kinase A Sales by Region (2027-2032) & (K Units) Table 50. Global Aurora Kinase A Sales Market Share by Region (2027-2032) Table 51. Global Aurora Kinase A Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Aurora Kinase A Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Aurora Kinase A Sales Value Share by Region (2021-2026) Table 54. Global Aurora Kinase A Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Aurora Kinase A Sales Value Share by Region (2027-2032) Table 56. Global Aurora Kinase A Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Aurora Kinase A Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Aurora Kinase A Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Aurora Kinase A Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Aurora Kinase A Sales by Country (2021-2026) & (K Units) Table 61. Global Aurora Kinase A Sales Market Share by Country (2021-2026) Table 62. Global Aurora Kinase A Sales by Country (2027-2032) & (K Units) Table 63. Global Aurora Kinase A Sales Market Share by Country (2027-2032) Table 64. Global Aurora Kinase A Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Aurora Kinase A Sales Value Market Share by Country (2021-2026) Table 66. Global Aurora Kinase A Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Aurora Kinase A Sales Value Market Share by Country (2027-2032) Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sanofi Aurora Kinase A Product Portfolio Table 72. Sanofi Recent Development Table 73. Merck & Co., Inc. Company Information Table 74. Merck & Co., Inc. Business Overview Table 75. Merck & Co., Inc. Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Merck & Co., Inc. Aurora Kinase A Product Portfolio Table 77. Merck & Co., Inc. Recent Development Table 78. Amgen Inc. Company Information Table 79. Amgen Inc. Business Overview Table 80. Amgen Inc. Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Amgen Inc. Aurora Kinase A Product Portfolio Table 82. Amgen Inc. Recent Development Table 83. AbbVie Inc. Company Information Table 84. AbbVie Inc. Business Overview Table 85. AbbVie Inc. Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. AbbVie Inc. Aurora Kinase A Product Portfolio Table 87. AbbVie Inc. Recent Development Table 88. Vichem Chemie Research Ltd. Company Information Table 89. Vichem Chemie Research Ltd. Business Overview Table 90. Vichem Chemie Research Ltd. Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio Table 92. Vichem Chemie Research Ltd. Recent Development Table 93. Vertex Pharmaceuticals Incorporated Company Information Table 94. Vertex Pharmaceuticals Incorporated Business Overview Table 95. Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio Table 97. Vertex Pharmaceuticals Incorporated Recent Development Table 98. Taiho Pharmaceutical Co., Ltd. Company Information Table 99. Taiho Pharmaceutical Co., Ltd. Business Overview Table 100. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio Table 102. Taiho Pharmaceutical Co., Ltd. Recent Development Table 103. Sigma-Tau S.p.A. Company Information Table 104. Sigma-Tau S.p.A. Business Overview Table 105. Sigma-Tau S.p.A. Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio Table 107. Sigma-Tau S.p.A. Recent Development Table 108. Sareum Holdings Plc Company Information Table 109. Sareum Holdings Plc Business Overview Table 110. Sareum Holdings Plc Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sareum Holdings Plc Aurora Kinase A Product Portfolio Table 112. Sareum Holdings Plc Recent Development Table 113. Millennium Pharmaceuticals, Inc. Company Information Table 114. Millennium Pharmaceuticals, Inc. Business Overview Table 115. Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio Table 117. Millennium Pharmaceuticals, Inc. Recent Development Table 118. CASI Pharmaceuticals Inc. Company Information Table 119. CASI Pharmaceuticals Inc. Business Overview Table 120. CASI Pharmaceuticals Inc. Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio Table 122. CASI Pharmaceuticals Inc. Recent Development Table 123. Astex Pharmaceuticals, Inc. Company Information Table 124. Astex Pharmaceuticals, Inc. Business Overview Table 125. Astex Pharmaceuticals, Inc. Aurora Kinase A Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio Table 127. Astex Pharmaceuticals, Inc. Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Aurora Kinase A Distributors List Table 131. Aurora Kinase A Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Aurora Kinase A Product Image Figure 2. Global Aurora Kinase A Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aurora Kinase A Sales Value (2021-2032) & (US$ Million) Figure 4. Global Aurora Kinase A Sales (2021-2032) & (K Units) Figure 5. Global Aurora Kinase A Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Aurora Kinase A Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. AMG-900 Image Figure 10. Ilorasertib Image Figure 11. ENMD-2076 Image Figure 12. Danusertib Image Figure 13. Others Image Figure 14. Global Aurora Kinase A Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Aurora Kinase A Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Aurora Kinase A Sales Volume Share by Type (2021-2032) Figure 17. Global Aurora Kinase A Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Aurora Kinase A Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Aurora Kinase A Sales Value Share by Type (2021-2032) Figure 20. Brain Tumor Image Figure 21. Ovarian Cancer Image Figure 22. Anaplastic Large Cell Lymphoma Image Figure 23. Others Image Figure 24. Global Aurora Kinase A Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Aurora Kinase A Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Aurora Kinase A Sales Volume Share by Application (2021-2032) Figure 27. Global Aurora Kinase A Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Aurora Kinase A Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Aurora Kinase A Sales Value Share by Application (2021-2032) Figure 30. Global Aurora Kinase A Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Aurora Kinase A Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Aurora Kinase A Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Aurora Kinase A Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Aurora Kinase A Sales Value (2021-2032) & (US$ Million) Figure 35. North America Aurora Kinase A Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Aurora Kinase A Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Aurora Kinase A Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Aurora Kinase A Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Aurora Kinase A Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Aurora Kinase A Sales Value (2021-2032) & (US$ Million) Figure 41. South America Aurora Kinase A Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Aurora Kinase A Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Aurora Kinase A Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Aurora Kinase A Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Aurora Kinase A Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Aurora Kinase A Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Aurora Kinase A Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Aurora Kinase A Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • AMG-900
  • Ilorasertib
  • ENMD-2076
  • Danusertib
  • Others
Applications
  • Brain Tumor
  • Ovarian Cancer
  • Anaplastic Large Cell Lymphoma
  • Others
Companies covered
  • Sanofi
  • Merck & Co., Inc.
  • Amgen Inc.
  • AbbVie Inc.
  • Vichem Chemie Research Ltd.
  • Vertex Pharmaceuticals Incorporated
  • Taiho Pharmaceutical Co., Ltd.
  • Sigma-Tau S.p.A.
  • Sareum Holdings Plc
  • Millennium Pharmaceuticals, Inc.
  • CASI Pharmaceuticals Inc.
  • Astex Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Aurora Kinase A Sales Value (2021-2032)
  4. 1.2.2 Global Aurora Kinase A Sales Volume (2021-2032)
  5. 1.2.3 Global Aurora Kinase A Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Aurora Kinase A Market Dynamics
  1. 2.1 Aurora Kinase A Industry Trends
  2. 2.2 Aurora Kinase A Industry Drivers
  3. 2.3 Aurora Kinase A Industry Opportunities and Challenges
  4. 2.4 Aurora Kinase A Industry Restraints
3 Aurora Kinase A Market by Company
  1. 3.1 Global Aurora Kinase A Company Revenue Ranking in 2025
  2. 3.2 Global Aurora Kinase A Revenue by Company (2021-2026)
  3. 3.3 Global Aurora Kinase A Sales Volume by Company (2021-2026)
  4. 3.4 Global Aurora Kinase A Average Price by Company (2021-2026)
  5. 3.5 Global Aurora Kinase A Company Ranking (2024-2026)
  6. 3.6 Global Aurora Kinase A Company Manufacturing Base and Headquarters
  7. 3.7 Global Aurora Kinase A Company Product Type and Application
  8. 3.8 Global Aurora Kinase A Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Aurora Kinase A Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Aurora Kinase A Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Aurora Kinase A Market by Type
  1. 4.1 Aurora Kinase A Type Introduction
  2. 4.1.1 AMG-900
  3. 4.1.2 Ilorasertib
  4. 4.1.3 ENMD-2076
  5. 4.1.4 Danusertib
  6. 4.1.5 Others
  7. 4.2 Global Aurora Kinase A Sales Volume by Type
  8. 4.2.1 Global Aurora Kinase A Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Aurora Kinase A Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Aurora Kinase A Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Aurora Kinase A Sales Value by Type
  12. 4.3.1 Global Aurora Kinase A Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Aurora Kinase A Sales Value by Type (2021-2032)
  14. 4.3.3 Global Aurora Kinase A Sales Value Share by Type (2021-2032)
5 Aurora Kinase A Market by Application
  1. 5.1 Aurora Kinase A Application Introduction
  2. 5.1.1 Brain Tumor
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Anaplastic Large Cell Lymphoma
  5. 5.1.4 Others
  6. 5.2 Global Aurora Kinase A Sales Volume by Application
  7. 5.2.1 Global Aurora Kinase A Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Aurora Kinase A Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Aurora Kinase A Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Aurora Kinase A Sales Value by Application
  11. 5.3.1 Global Aurora Kinase A Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Aurora Kinase A Sales Value by Application (2021-2032)
  13. 5.3.3 Global Aurora Kinase A Sales Value Share by Application (2021-2032)
6 Aurora Kinase A Regional Sales and Value Analysis
  1. 6.1 Global Aurora Kinase A Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Aurora Kinase A Sales by Region (2021-2032)
  3. 6.2.1 Global Aurora Kinase A Sales by Region: 2021-2026
  4. 6.2.2 Global Aurora Kinase A Sales by Region (2027-2032)
  5. 6.3 Global Aurora Kinase A Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Aurora Kinase A Sales Value by Region (2021-2032)
  7. 6.4.1 Global Aurora Kinase A Sales Value by Region: 2021-2026
  8. 6.4.2 Global Aurora Kinase A Sales Value by Region (2027-2032)
  9. 6.5 Global Aurora Kinase A Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Aurora Kinase A Sales Value (2021-2032)
  12. 6.6.2 North America Aurora Kinase A Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Aurora Kinase A Sales Value (2021-2032)
  15. 6.7.2 Europe Aurora Kinase A Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Aurora Kinase A Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Aurora Kinase A Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Aurora Kinase A Sales Value (2021-2032)
  21. 6.9.2 South America Aurora Kinase A Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Aurora Kinase A Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Aurora Kinase A Sales Value Share by Country, 2025 VS 2032
7 Aurora Kinase A Country-level Sales and Value Analysis
  1. 7.1 Global Aurora Kinase A Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Aurora Kinase A Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Aurora Kinase A Sales by Country (2021-2032)
  4. 7.3.1 Global Aurora Kinase A Sales by Country (2021-2026)
  5. 7.3.2 Global Aurora Kinase A Sales by Country (2027-2032)
  6. 7.4 Global Aurora Kinase A Sales Value by Country (2021-2032)
  7. 7.4.1 Global Aurora Kinase A Sales Value by Country (2021-2026)
  8. 7.4.2 Global Aurora Kinase A Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Aurora Kinase A Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Aurora Kinase A Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Aurora Kinase A Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Aurora Kinase A Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Aurora Kinase A Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Aurora Kinase A Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Aurora Kinase A Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Aurora Kinase A Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Aurora Kinase A Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Aurora Kinase A Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Aurora Kinase A Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Aurora Kinase A Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Aurora Kinase A Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Aurora Kinase A Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Aurora Kinase A Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Aurora Kinase A Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Aurora Kinase A Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Aurora Kinase A Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Aurora Kinase A Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Aurora Kinase A Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Aurora Kinase A Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Aurora Kinase A Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Aurora Kinase A Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Aurora Kinase A Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Aurora Kinase A Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Aurora Kinase A Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Aurora Kinase A Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Aurora Kinase A Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Aurora Kinase A Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Aurora Kinase A Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Aurora Kinase A Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Aurora Kinase A Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 Amgen Inc.
  14. 8.3.1 Amgen Inc. Company Information
  15. 8.3.2 Amgen Inc. Business Overview
  16. 8.3.3 Amgen Inc. Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Amgen Inc. Aurora Kinase A Product Portfolio
  18. 8.3.5 Amgen Inc. Recent Developments
  19. 8.4 AbbVie Inc.
  20. 8.4.1 AbbVie Inc. Company Information
  21. 8.4.2 AbbVie Inc. Business Overview
  22. 8.4.3 AbbVie Inc. Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AbbVie Inc. Aurora Kinase A Product Portfolio
  24. 8.4.5 AbbVie Inc. Recent Developments
  25. 8.5 Vichem Chemie Research Ltd.
  26. 8.5.1 Vichem Chemie Research Ltd. Company Information
  27. 8.5.2 Vichem Chemie Research Ltd. Business Overview
  28. 8.5.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio
  30. 8.5.5 Vichem Chemie Research Ltd. Recent Developments
  31. 8.6 Vertex Pharmaceuticals Incorporated
  32. 8.6.1 Vertex Pharmaceuticals Incorporated Company Information
  33. 8.6.2 Vertex Pharmaceuticals Incorporated Business Overview
  34. 8.6.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio
  36. 8.6.5 Vertex Pharmaceuticals Incorporated Recent Developments
  37. 8.7 Taiho Pharmaceutical Co., Ltd.
  38. 8.7.1 Taiho Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Taiho Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio
  42. 8.7.5 Taiho Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Sigma-Tau S.p.A.
  44. 8.8.1 Sigma-Tau S.p.A. Company Information
  45. 8.8.2 Sigma-Tau S.p.A. Business Overview
  46. 8.8.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio
  48. 8.8.5 Sigma-Tau S.p.A. Recent Developments
  49. 8.9 Sareum Holdings Plc
  50. 8.9.1 Sareum Holdings Plc Company Information
  51. 8.9.2 Sareum Holdings Plc Business Overview
  52. 8.9.3 Sareum Holdings Plc Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sareum Holdings Plc Aurora Kinase A Product Portfolio
  54. 8.9.5 Sareum Holdings Plc Recent Developments
  55. 8.10 Millennium Pharmaceuticals, Inc.
  56. 8.10.1 Millennium Pharmaceuticals, Inc. Company Information
  57. 8.10.2 Millennium Pharmaceuticals, Inc. Business Overview
  58. 8.10.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
  60. 8.10.5 Millennium Pharmaceuticals, Inc. Recent Developments
  61. 8.11 CASI Pharmaceuticals Inc.
  62. 8.11.1 CASI Pharmaceuticals Inc. Company Information
  63. 8.11.2 CASI Pharmaceuticals Inc. Business Overview
  64. 8.11.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio
  66. 8.11.5 CASI Pharmaceuticals Inc. Recent Developments
  67. 8.12 Astex Pharmaceuticals, Inc.
  68. 8.12.1 Astex Pharmaceuticals, Inc. Company Information
  69. 8.12.2 Astex Pharmaceuticals, Inc. Business Overview
  70. 8.12.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
  72. 8.12.5 Astex Pharmaceuticals, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Aurora Kinase A Value Chain Analysis
  2. 9.1.1 Aurora Kinase A Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Aurora Kinase A Sales Mode & Process
  6. 9.2 Aurora Kinase A Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Aurora Kinase A Distributors
  9. 9.2.3 Aurora Kinase A Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst